AAV Transfer Plasmids Explained: Viral Vector Components & Elements

Added:

Plasmid-Free AAV Production: Minicircle and dbDNA Alternatives

While traditional AAV transfer plasmids are the standard for viral vector production, they present significant limitations, including the risk of transferring bacterial backbone sequences and antibiotic resistance genes into host cells. This has led to a shift toward plasmid-free DNA technologies, such as Minicircle DNA and Doggybone DNA (dbDNA). These minimal DNA templates eliminate the bacterial plasmid backbone entirely, reducing the risk of undesirable immune responses and improving the safety, purity, and expression efficiency of the resulting AAV vectors for clinical gene therapy.

Basic Molecular Biology & Central Dogma: Understanding gene expression mechanisms, including transcription (promoters) and translation.
Structure and Function of Plasmids: Knowledge of circular DNA molecules used in biotechnology, including selection markers and origins of replication.
Introduction to Adeno-Associated Virus (AAV): A basic understanding of AAV as a non-pathogenic, single-stranded DNA virus used as a vehicle in gene therapy.
Concept of Viral Vectors: Familiarity with how modified viruses are engineered to deliver genetic material into host cells.
AAV Triple Transfection Method: Learning how transfer plasmids work alongside helper and packaging plasmids (Rep/Cap) to produce functional viral particles in packaging cells (e.g., HEK293).
Promoter Selection and Tissue Specificity: Exploring how to choose or engineer specific promoters (e.g., muscle-specific, neuron-specific) to restrict transgene expression to target tissues.
AAV Capsid Engineering & Serotypes: Studying how different AAV serotypes affect cellular tropism and how capsids can be engineered to evade the host immune system.
Clinical Applications of Gene Therapy: Investigating real-world therapeutic applications, regulatory hurdles, and FDA-approved AAV-based drugs (e.g., Luxturna, Zolgensma).
39.2K views547likes4:47@addgeneOriginal Release: 2019-10-18

AAV transfer plasmids contain essential elements including inverted terminal repeats (ITRs) that define the packaged region, a transgene positioned downstream of a promoter for expression, and optional regulatory elements like lox sites for controlled activation and WPRE/poly(A) sequences for enhanced expression; these components work together to ensure successful gene delivery and expression when the AAV vector is delivered to a host.